Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADC4022 inhaled theophylline pilot study in moderate to severe COPD
2007-001968-78Phase 2Completed
- Sponsor
- Argenta Discovery
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ADC4022 in chronic obstructive pulmonary disease (COPD), sponsored by Argenta Discovery. Started May 2007; status: completed.
02
Drugs
ADC4022
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2007-001968-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001968-78.